Literature DB >> 33271312

Molecular basis of transcriptional pausing, stalling, and transcription-coupled repair initiation.

Juntaek Oh1, Jun Xu1, Jenny Chong1, Dong Wang2.   

Abstract

Transcription elongation by RNA polymerase II (Pol II) is constantly challenged by numerous types of obstacles that lead to transcriptional pausing or stalling. These obstacles include DNA lesions, DNA epigenetic modifications, DNA binding proteins, and non-B form DNA structures. In particular, lesion-induced prolonged transcriptional blockage or stalling leads to genome instability, cellular dysfunction, and cell death. Transcription-coupled nucleotide excision repair (TC-NER) pathway is the first line of defense that detects and repairs these transcription-blocking DNA lesions. In this review, we will first summarize the recent research progress toward understanding the molecular basis of transcriptional pausing and stalling by different kinds of obstacles. We will then discuss new insights into Pol II-mediated lesion recognition and the roles of CSB in TC-NER.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage; DNA repair; Nucleosome bypass; RNA polymerase II; Transcription elongation; Transcriptional arrest

Mesh:

Substances:

Year:  2020        PMID: 33271312      PMCID: PMC7836393          DOI: 10.1016/j.bbagrm.2020.194659

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  125 in total

1.  Structural basis for the dual coding potential of 8-oxoguanosine by a high-fidelity DNA polymerase.

Authors:  Luis G Brieba; Brandt F Eichman; Robert J Kokoska; Sylvie Doublié; Tom A Kunkel; Tom Ellenberger
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Efficient and rapid nucleosome traversal by RNA polymerase II depends on a combination of transcript elongation factors.

Authors:  Donal S Luse; Lisa C Spangler; Andrea Újvári
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 3.  The role of chromatin during transcription.

Authors:  Bing Li; Michael Carey; Jerry L Workman
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 4.  Conserved RNA polymerase II initiation complex structure.

Authors:  Merle Hantsche; Patrick Cramer
Journal:  Curr Opin Struct Biol       Date:  2017-04-22       Impact factor: 6.809

Review 5.  DNA interstrand crosslink repair and cancer.

Authors:  Andrew J Deans; Stephen C West
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

6.  UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair.

Authors:  Petra Schwertman; Anna Lagarou; Dick H W Dekkers; Anja Raams; Adriana C van der Hoek; Charlie Laffeber; Jan H J Hoeijmakers; Jeroen A A Demmers; Maria Fousteri; Wim Vermeulen; Jurgen A Marteijn
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

7.  Human transcription-repair coupling factor CSB/ERCC6 is a DNA-stimulated ATPase but is not a helicase and does not disrupt the ternary transcription complex of stalled RNA polymerase II.

Authors:  C P Selby; A Sancar
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

8.  Transcription factors IIS and IIF enhance transcription efficiency by differentially modifying RNA polymerase pausing dynamics.

Authors:  Toyotaka Ishibashi; Manchuta Dangkulwanich; Yves Coello; Troy A Lionberger; Lucyna Lubkowska; Alfred S Ponticelli; Mikhail Kashlev; Carlos Bustamante
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

9.  Molecular basis of transcriptional mutagenesis at 8-oxoguanine.

Authors:  Gerke E Damsma; Patrick Cramer
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

10.  Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair.

Authors:  Yuka Nakazawa; Kensaku Sasaki; Norisato Mitsutake; Michiko Matsuse; Mayuko Shimada; Tiziana Nardo; Yoshito Takahashi; Kaname Ohyama; Kosei Ito; Hiroyuki Mishima; Masayo Nomura; Akira Kinoshita; Shinji Ono; Katsuya Takenaka; Ritsuko Masuyama; Takashi Kudo; Hanoch Slor; Atsushi Utani; Satoshi Tateishi; Shunichi Yamashita; Miria Stefanini; Alan R Lehmann; Koh-ichiro Yoshiura; Tomoo Ogi
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

View more
  6 in total

1.  DEF1: Much more than an RNA polymerase degradation factor.

Authors:  Oluwasegun T Akinniyi; Joseph C Reese
Journal:  DNA Repair (Amst)       Date:  2021-08-05

Review 2.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

3.  Crucial role and mechanism of transcription-coupled DNA repair in bacteria.

Authors:  Binod K Bharati; Manjunath Gowder; Fangfang Zheng; Khaled Alzoubi; Vladimir Svetlov; Venu Kamarthapu; Jacob W Weaver; Vitaly Epshtein; Nikita Vasilyev; Liqiang Shen; Yu Zhang; Evgeny Nudler
Journal:  Nature       Date:  2022-03-30       Impact factor: 69.504

4.  RNA polymerase II trapped on a molecular treadmill: Structural basis of persistent transcriptional arrest by a minor groove DNA binder.

Authors:  Juntaek Oh; Tiezheng Jia; Jun Xu; Jenny Chong; Peter B Dervan; Dong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 11.205

Review 5.  Genome-wide mapping of genomic DNA damage: methods and implications.

Authors:  Stefano Amente; Giovanni Scala; Barbara Majello; Somaiyeh Azmoun; Helen G Tempest; Sanjay Premi; Marcus S Cooke
Journal:  Cell Mol Life Sci       Date:  2021-08-31       Impact factor: 9.261

Review 6.  RNA polymerase pausing, stalling and bypass during transcription of damaged DNA: from molecular basis to functional consequences.

Authors:  Aleksei Agapov; Anna Olina; Andrey Kulbachinskiy
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.